Ligand Pharmaceuticals Incorporated · NASDAQ:LGND

Reardon Andrew sold 5,000 Ligand Pharmaceuticals Incorporated shares (Form 4)

Traded Oct 2, 2026 · Filed Oct 6, 2026

On Oct 2, 2026, Reardon Andrew (CLO & Secretary) sold 5,000 Ligand Pharmaceuticals Incorporated shares at an average US$304.07 for US$1.52M under a trading plan, leaving 31,854 shares. Filed Oct 6, 2026 (Form 4).

Sold
5,000 shares
Price
US$304.07 average (US$302.51 to US$307.74)
Value
US$1.52M
Holding after
31,854 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CLO & Secretary

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 2, 2026Common StockOption exercise340US$52.2736,854Direct
Oct 2, 2026Common StockSale833US$302.5136,021Direct
Oct 2, 2026Common StockSale1,976US$303.5434,045Direct
Oct 2, 2026Common StockSale1,535US$304.5232,510Direct
Oct 2, 2026Common StockSale404US$306.1832,106Direct
Oct 2, 2026Common StockSale235US$307.1931,871Direct
Oct 2, 2026Common StockSale17US$307.7431,854Direct

Source

View original at SEC

Related